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Single neuron transcriptomics 
identify SRSF/SR protein B52 as 
a regulator of axon growth and 
Choline acetyltransferase splicing
Boyin Liu1 & Torsten Bossing2
We removed single identified neurons from living Drosophila embryos to gain insight into the 
transcriptional control of developing neuronal networks. The microarray analysis of the transcriptome 
of two sibling neurons revealed seven differentially expressed transcripts between both neurons 
(threshold: log21.4). One transcript encodes the RNA splicing factor B52. Loss of B52 increases growth 
of axon branches. B52 function is also required for Choline acetyltransferase (ChAT ) splicing. At the end 
of embryogenesis, loss of B52 function impedes splicing of ChAT, reduces acetylcholine synthesis, and 
extends the period of uncoordinated muscle twitches during larval hatching. ChAT regulation by SRSF 
proteins may be a conserved feature since changes in SRSF5 expression and increased acetylcholine 
levels in brains of bipolar disease patients have been reported recently.
One of the most complicated puzzles in brain development is how genes direct the formation of neuronal circuits 
that control a multitude of behaviours ranging from simple locomotion to complex social interactions. The fruit 
fly Drosophila is one of the most widely used neurogenetic models1,2. The systematic mapping of the stereotyped 
location and morphology of neurons and glial cells has made Drosophila one of the few organisms in which most 
of the components of the central nervous system (CNS) have been described3–6. The knowledge about the CNS 
building blocks combined with the ease and wealth of genetic manipulations available in Drosophila has acceler-
ated our understanding of how genes determine cell fate, the pattern of division of neural stem cells, how axons 
navigate towards their target, and how synapses are formed and maintained7–9. The output of neural computation 
in the CNS directs the behaviour of an organism. Drosophila also has a long legacy in behavioural studies encom-
passing sexual behaviour, memory, circadian rhythms, taste, aggression, addiction among many others10,11. In 
the last few years Drosophila neurobiology has started to combine cellular with behavioural studies and to set 
out to identify all components and their connections making up neural circuits. The identification of each circuit 
becomes feasible because of the advent of public repositories of large sets of transgenic Drosophila stocks, which 
allows genetic manipulation and labelling of small subsets of identified neurons3. In addition, the invention of 
new tools allows limiting the expression in these subsets even further down to single cells12. Together, these tools 
allow the 3D construction by immunofluorescence and electron microscopy of neuronal circuits and the targeted 
activation, recording and silencing of neuronal subsets in a circuit13–15. Yet, to test the function of each connection 
and to predict the outcome of circuit activation, more information is needed about how each axon recognises its 
target, how an initial contact is stabilised and maintained, and finally which neurotransmitters and receptors are 
present at the newly formed synapse. Most of this information can be obtained by analysing the transcriptome of 
single neurons over time.
The availability of single cell driver lines enables cell purification using FACS (fluorescent activated cell sort-
ing) or MACS (magnetic activated cell sorting) alone or in combination as a convenient method to enrich for 
specific cell types. Yet, these purifications often suffer from incomplete cell dissociation and/or the potential 
danger of transcriptional changes caused by transient cell culture16–20. To avoid cell dissociation, methods of 
tagging newly synthesized or translated RNA, such as PABP, TRAP or TU tagging, have been developed21–23. 
These methods allow RNA purification from lysed tissue but like MACS and FACS it is difficult to estimate the 
level of purity. Most recently, the isolation of nuclei tagged in specific cell types (INTACT) using a genetic tag 
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has been designed to analyse the transcriptome of identified cells24. To be useful for single cell transcriptomics 
all these methods depend on the availability of transgenic animals, which only label a single cell type. In addition 
both methods often collect material from different animals capturing differences in transcription, which may be 
caused by differences in genetic background or nutrition and not by cell type. We recently developed a method, 
which allows the analysis of the transcriptome of single cells taken directly from living Drosophila embryos on 
whole genome microarrays25. Since cells are removed with a microcapillary, single cell labelling is not required 
and more than one cell can be removed and compared separately from the same embryo avoiding non cell-type 
specific differences.
Here we use our established method to identify transcriptional changes in two well-characterised embryonic 
Drosophila interneurons, vMP2 and dMP2, at the time when neural networks become functional26. We selected 
one of the identified transcripts, B52, which encodes a member of the Serine-rich splicing factor (SRSF) fam-
ily, for functional analysis. Although B52 is widely expressed in the CNS including MP2 neurons, transcript 
expression appears higher in dMP2 than in vMP2. We were unable to detect any morphological or behavourial 
phenotype for the neural gain of B52 expression. Neural depletion of B52 function in the embryo increased the 
growth of the posterior axonal branch of the dMP2 neuron, interfered with the splicing of ChAT pre-mRNA 
and decreased the synthesis of ChAT. Reduced acetylcholine synthesis is most likely the cause for the delayed 
maturation in larval locomotion and the delay in hatching observed in B52 depleted animals. In summary, our 
experiments show that the analysis of the transcriptome of single neurons directly harvested from live brains is a 
powerful tool to identify transcripts with important functions in neuronal circuit formation.
Results
Transcriptional analysis of two single sibling neurons during neuronal network formation. We 
set out to test if the removal of single neurons from living Drosophila embryos and the subsequent analysis of their 
transcriptome would yield new insights into the formation of neuronal communication. To facilitate the func-
tional analysis of identified transcripts we focused on the two MP2 sibling neurons, since these are a longstanding 
model system for neuronal development and offer readily available immunohistochemical as well as transgenic 
tools27,28. The simplest neuroblast lineage in the Drosophila CNS arises from the MP2 neural precursor (Fig. 1A). 
The precursor divides asymmetrically to give rise to a smaller, ventrally located neuron (vMP2), which projects 
anteriorly and a bigger, dorsally located neuron (dMP2), which projects posteriorly5,27. vMP2 s differentiate into 
cholinergic interneurons (Fig. 1B) whereas most thoracic and abdominal dMP2 neurons differentiate into pro-
jecting interneurons, which will die shortly before larval hatching. Immunohistochemistry did not detect ChAT, 
vGlut, Serotonin, Dopamine or GABA expression in dMP2 neurons (data not shown). dMP2 neurons located in 
posterior abdominal segments (A6–A9) survive, innervate hind- and midgut, and express and secrete insulin-like 
peptide 729. We removed vMP2 and dMP2 neurons from the first abdominal segment (A1) of living embryos at 
17 h of embryogenesis (Fig. 1D). Cell death of dMP2 neurons has first been reported at 19 h of embryogenesis29. 
Towards the end of embryogenesis (17 h after egg lay) action potentials can first be recorded from Drosophila neu-
rons indicating the initiation of functional neuronal networks26. Using our established protocol25, four single MP2 
siblings were removed from two different embryos (one sibling pair/embryo), the RNA was reverse transcribed 
and after amplification analysed on whole genome microarrays (FlyChip). Using stringent conditions, at 17 h 
MP2 sibling neurons show a very low number of differentially expressed transcripts (Table 1).
To validate our study, we focused on the analysis of B52, which belongs to the evolutionary conserved SRSF 
protein family of pre-mRNA splicing factors including the B52 orthologues SRSF4 and 5, which are expressed 
in the human brain30,31. We used in situ hybridisation to detect B52 mRNA. In the CNS, B52 is widely expressed 
throughout embryogenesis (Fig. 2, Supplementary Fig. S1). Using 22C10/MAP1B as a marker for MP2 interneu-
rons and aCC motor neurons32, we observed B52 relative mRNA amounts significantly higher in dMP2 than in 
vMP2 interneurons or aCC motor neurons (Fig. 2, Supplementary Fig. S1). We conclude that both, our microar-
ray analysis and in situ RNA detection, support differential expression of B52 mRNA in MP2 neurons.
Loss of B52 delays larval hatching without interfering with neuronal determination or gross 
axonal guidance. To overcome maternally deposited B52 protein33, we decided to interfere with B52 func-
tion by expressing a B52 binding site aptamer (UAS-BBS/+; elav-GAL4) in all embryonic neurons and neuro-
blasts. The aptamer delivers 60 B52 binding sites (BBS) arranged as a dodecamer of self-folding RNA molecules 
with five B52 optimised binding sites each. Expression of BBS has been shown to bind B52 thereby acting as B52 
functional antagonist34. Depletion of B52 function in the embryonic CNS significantly delays larval hatching 
by nearly 1 h (25 oC, Fig. 3A). Using tracheal filling as a start point, control embryos (elav-GAL4) take 3.86 h 
(+/−0.1 h, n = 38), whereas embryos with reduced B52 function take on average 4.76 h (+/−0.36 h, n = 37, 
p = 0.02). Since B52 mRNA is expressed throughout embryogenesis, a delay in hatching may indicate changes 
in neural stem cell determination, cell division or axonal guidance. To test for these changes, we depleted a small 
subset of neural stem cells and their progeny of B52 function (UAS-BBS/+; eag-GAL4,UAS-CD8-GFP). We were 
not able to detect any changes in cell morphology and cell number in the B52 depleted lineages (Fig. 3B,C). 
Depletion of B52 function also does not interfere with the guidance of motorneuronal axons and endplates 
(anti-Fasciclin II; Fig. 3D,E). Finally we labelled single neural stem cells with the fluorescent dye DiI35 to follow 
cell division and cell differentiation in embryos with (n = 32) and without (n = 22) B52 depleted function. We 
observed no changes in cell determination or cell division (Fig. 3F–K).
It is possible that interference with B52 function via expression of BBS does not sufficiently decrease B52 activity, 
explaining the lack of gross morphological phenotypes. Therefore we generated a B52 null mutant by imprecise 
P-element excision (see Material and Methods for characterization of mutant). B52∆S2249 mutant embryos do not 
show any hatching delay (Fig. 3A) but show retarded larval growth (Supplementary Movie S1), run out of B52 
mRNA around 36 h (see below) and die around 40 h after larval hatching. The CNS of 36 h old B52∆S2249 larvae are 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:34952 | DOI: 10.1038/srep34952
28% narrower than their heterozygous siblings or wild type embryos (n = 5, for both genotypes) but mutant CNSs 
show no obvious changes in their axonal scaffold (anti-Fasciclin II; Fig. 3L,M).
Figure 1. Transcriptional analysis of MP2 neurons. (A) The MP2 neural precursor divides only once to 
give rise to a vMP2 and a dMP2 interneuron. Both sibling neurons extend axons in opposite directions. 
(B,C) A MP2 precursor was labelled with the fluorescent dye DiI (red) in embryos expressing membrane 
bound green fluorescent protein (GFP) in cholinergic neurons (ChAT-GAL4/UAS-CD8-GFP). Embryos were 
allowed to develop for 17h after egg lay (ael). At this stage, vMP2 (arrow) has differentiated into an anterior 
projecting (arrow), cholinergic and dMP2 (arrowhead) into a posterior (arrowhead) projecting interneuron. 
C shows red channel only. (D) At 17 h ael both sibling neurons were separately removed with a capillary under 
epifluorescence and their transcriptomes were reverse transcribed, amplified and compared on whole genome 
microarrays. Horizontal views, Anterior is up; Scale bar: 10 μm (B,C).
www.nature.com/scientificreports/
4Scientific RepoRts | 6:34952 | DOI: 10.1038/srep34952
In summary, depletion of B52 function in the embryo seems not to interfere with neural stem cell determination, 
cell division or axonal guidance but causes a delay in larval hatching.
Loss of B52 increases axonal growth. To analyse on a single neuron level the phenotype caused by deple-
tion of B52 function, we turned our focus back to dMP2 neurons. Labelling of dMP2s was performed by gener-
ating mosaic clones expressing myr-GFP36 into GAL4CY27 strain. GAL4CY27 drives expression strongly in dMP2 
neurons, and transiently in vMP2 neurons plus a subset of late delaminating neuroblasts. Depletion of B52 func-
tion (UAS-BBS/+; Gal4CY27/+) increased anterior branch length by nearly 52% and posterior branch length by 
46% (Fig. 4). In contrast, increased expression of full length B52 (UAS-GFP-B52/+; Gal4Cy27/+) did not interfere 
with growth of dMP2 axons branches (Fig. 4). We conclude that reduction of B52 function in dMP2 increases 
axonal growth.
Loss of B52 interferes with maturation of larval movements, splicing of pre-mRNA and protein 
synthesis of ChAT. To obtain insight into the causes of hatching delays as a result of depletion of B52 func-
tion, we recorded larval movements and analysed the muscle contractions during a 2 h period starting from 
tracheal filling following neural expression of B52-RNAi or BBS. In wild type larvae movements first undergo 
a phase of uncoordinated muscle twitches lasting about 90 min until tracheal filling. After tracheal filling these 
short twitches are gradually replaced with coordinated waves of muscle contraction37. We defined short twitches 
as muscle contractions lasting up to 10 sec, occuring only unilaterally and often only in one segment. In con-
trast, long contractions last longer than 10 sec, pass through more than one segment, are bilateral and often 
include more than one peristaltic wave passing through the larvae. Compared to elav-GAL4, (Supplementary 
Movie S2) we observed in embryos where B52 function is reduced by neural expression of B52-RNAi 
(elav-GAL4/UAS-B52RNAi) a slight hatching delay and we find a significant increase in the number of short 
twitches (p = 0.011, Fig. 5A). Only a slight hatching delay upon B52-RNAi expression is not surprising as mater-
nal B52 protein is still abundant at this age. In contrast, embryos in which B52 function is depleted by BBS 
expression (UAS-BBS/+; elav-GAL4/+) show delayed hatching and a threefold increase in the frequency of short 
twitches (p < 0.001; Fig. 5A, Supplementary Movie S3). No differences in the number of long contractions were 
observed (Fig. 5A). We conclude that B52 functional depletion delays the maturation of larval movement by 
extending the phase of uncoordinated twitching beyond tracheal filling.
Gene wrapper CG31855 CG7433 B52 fis1 trx DMAP1
Fold Expression  
(log2FC dMP2 vs vMP2)
6.06 4.27 3.96 3.92 1.64 −2.84 −3.53
Function Neurexin IV receptor
Ubiquitin 
ligase Trans-aminase
Splicing 
Factor Mitochondria
Chromatin 
binding
Chromatin 
binding
Table 1.  Differentially expressed transcripts detected in dMP2 versus vMP2 neurons. At 17 h in embryonic 
development, dMP2 and vMP2 neurons are highly similar. In two biological replicates, only 7 out of 2631 
transcripts show changes in expression levels of more than 1.4 fold up or down, have a high spot quality of 8 or 
more and a p-value below 0.05. Log2FC: Logarithmic base 2 Fold Change in expression levels.
Figure 2. B52 mRNA is expressed higher in dMP2 than vMP2 or aCC. (A–D) Panels show in situ 
hybridisation using sense mRNA as negative control (control, green) or anti-sense mRNA (B52 mRNA, green) 
to detect B52 endogenous mRNA. vMP2, dMP2 interneurons and aCC motor neuron are detected by 22C10 
antigen expression (red) and cells are outlined. (C,D) shows in situ signal only. Anterior is up. Scale, 5 μm (E) 
Quantification of in situ signal in vMP2, dMP2 and aCC. Sense signal is equal in all three cells but anti-sense 
signal detecting B52 mRNA is significantly stronger (p < 0.01, t-test) in dMP2 than vMP2. Bars are standard 
error. For each condition, sense and antisense, and cell type, 10 cells in three different embryos were measured.
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Figure 3. Loss of B52 function delays larval hatching, but does not interfere with determination, 
cell division and axon guidance. The genotypes are indicated at the top of each figure: elav-GAL4 and, 
B52ΔS2249/TM3, control; UAS-BBS/+; elav-GAL4/+, B52 depletion; eag-GAL4, UAS-CD8-GFP, control;  
UAS-BBS/+; eag-GAL4, UAS-CD8-GFP/+, B52 depletion; B52ΔS2249, B52 null mutant. (A) Time for larval 
hatching for elav-GAL4 (n = 38), UAS-BBS/+; elav-GAL4/+ (n = 37) and homozygous B52ΔS2249 mutants 
(n = 21) was measured starting at tracheal filling. Depletion of B52 function delays hatching by nearly 1 h 
(p = 0.02, t-test). B52ΔS2249 mutant embryos show no hatching delay. Error bars represent standard error.  
(B,C) Loss of B52 does not interfere with neuronal determination and differentiation. Neural precursors 2-4, 
3-3, 6-4, 7-3 and their progeny are labelled by the expression of membrane-bound GFP (green, eg-GAL4/ 
UAS-myr-GFP). At embryonic stage 17, no differences in cell number, differentiation and axonal projection 
between wild type and depletion of B52 function can be observed. (D,E) At stage 17, motorneurons were 
labelled with Fasciclin II antisera (red). Depletion of B52 does not affect muscle innervation. (F–K) Single 
neural precursors were labelled with the fluorescent dye, DiI (red), and their development followed in vivo.  
At stage 17, embryos were fixed, immunostained and the clones were recorded by confocal microscopy. Clones 
derived from precursor MP2, 3-1, 2-1 and 5-2 are shown. Depletion of B52 function does not interfere with 
neuronal determination, cell division or axon guidance. No changes in the axon scaffold (green, BP102) can be 
detected. (L,M) Axon projection pattern (red, FasII) in the CNS of 36 h post-hatching B52 homozygous mutant 
larvae are indistinguishable from wild type. Horizontal views, Anterior is up. Scale: 10 μm.
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Cholinergic interneurons are the major excitatory input for motorneurons, and control the development of 
the two phases of larval movement, twitching and long contractions38,39. Inhibitory GAB Aergic interneurons 
seem not to be involved in this process40. Since one of the main functions of B52 is pre-mRNA splicing41 we 
sought to investigate if B52 may also control the splicing of Choline-acetyltransferase (ChAT), which encodes the 
enzyme involved in the last step of the biosynthesis of the neurotransmitter acetylcholine. We focused on the 
splicing of intron 2 and introns 4–7 of ChAT pre-mRNA. Indeed, a semi-quantitative analysis by RT-PCR of RNA 
extracted from 19 h old embryonic CNS (stage 17) shows that neural depletion of B52 function (UAS-BBS/+; 
elav-GAL4/+) reduces splicing of intron 2 and introns 4–7 of ChAT (Fig. 5B). This lack of efficient splicing leads 
to a reduction in ChAT protein synthesis (Fig. 5C). We also tested if the reduction of ChAT synthesis would lower 
Figure 4. Loss of B52 increases axon extension. Genotypes indicated at the top of each picture are: GAL4CY27, 
control; UAS-BBS/+; GAL4CY27/+, B52 depletion; GAL4CY27/UAS-GFP-B52, gain of B52. Odd; Odd-skipped, 
transcription factor labelling MP1 and dMP2 neurons. (A–C) Mosaic clones were generated by injection 
of UAS-myr-GFP (green) plasmids into syncytial blastoderm embryos. (B) Only depletion of B52 function 
increases the length of the posterior branch of the dMP2 neuron (p = 0.002, t-test). (C) Expression of GFP-B52 
(green) does not increase the length of axonal branches. GFP-B52 accumulates in the nucleus of dMP2 resulting 
in an overlap with the nuclear transcription factor Odd (red). Outline and axons of dMP2 are labelled by 
expression of the membrane bound myr-GFP. Horizontal views, Anterior is up. Scale, 10 μm. (D) Depletion but 
not gain of B52 function affects axon extension. N = 9 for all genotypes. Error bar indicates standard error.
www.nature.com/scientificreports/
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Figure 5. Depletion of B52 function affects larval hatching and Choline acteyltransferase (ChAT) splicing 
and synthesis. Genotypes are indicated at the top or bottom of each panel: elav-GAL4, control; UAS-BBS/+; 
elav-GAL4/+ and elav-GAL4/UAS-B52RNAi, B52 depletion; elav-GAL4/UAS-GFP-B52, gain of B52; B52ΔS2249, 
B52 homozygous mutant. (A) Compared to elav-GAL4 larvae, larvae depleted of B52 function, either by 
expression of RNAi (p = 0.011) or BBS (p < 0.001, t-test), show an increase in short muscle contractions, 
short twitches (blue) which last up to 10 sec and often occur unilaterally in each segment. Depletion of B52 
function does not alter the frequency of long bilateral muscle contractions (red), which last longer than 10 sec. 
www.nature.com/scientificreports/
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acetylcholine synthesis. We discovered that acetylcholine synthesis is reduced by 80% in embryos after neural 
depletion of B52 function (Fig. 5D).
There is only a slight reduction of ChAT protein in B52 homozygous mutants (Fig. 5C), which do not show 
any hatching delay and only run out of B52 transcript 36 h after larval hatching.
In 36 h post-hatching B52∆S2249 mutant larvae, shortly before they contract permanently, B52 RNA is barely 
detectable (Fig. 6A, top) but surprisingly introns 4–7 are spliced as efficiently as in control embryos (Fig. 6A, 
bottom). Loss of only one copy of B52 in heterozygotes (B52∆S2249/TM3GFP) reduces B52 mRNA (Fig. 6A, top) and 
interferes with splicing of introns 4–7, an effect which can also be seen in the increased neural expression of B52 
(elav-GAL4/UAS-GFP-B52; Fig. 6A, bottom). B52 does not affect splicing of all introns in the ChAT pre-mRNA. 
The coding sequence (CDS) for the vesicular acetylcholine transporter (vAChT) is located inside the first intron 
of the ChAT CDS and originates from an alternative splicing of the ChAT CDS. vAChT has only one intron and 
splicing is not affected by gain or by loss of B52 (Supplementary Fig. S2).
The rigidity of the B52∆S2249 homozygous mutant 2nd instar larvae indicates that hyper-contraction and not 
failure of contraction of muscles may be the cause for the observed paralysis (Supplementary Movie S3). We 
tested if immobility might be caused by changes in the interneuronal neurotransmitter acetylcholine or the 
motorneuronal neurotransmitter glutamate. First, we measured acetylcholine levels in 36 h larval nerve cords. 
We did not detect changes in acetylcholine levels between heterozygous and homozygous mutants (Fig. 6B). 
Second, we examined ChAT and vGlut protein levels at 36 h after larval hatching, ChAT protein synthesis is not 
significantly altered in homozygous B52∆S2249 mutants as compared to their heterozygous siblings or elav-GAL4 
larvae (Fig. 6C, top). Also, raising neural B52 levels (elav-GAL4/UAS-GFP-B52) does not affect ChAT synthesis 
(Fig. 6C). We used the vesicular Glutamate transporter (vGlut) as indicator for glutamate levels42. Gain or loss 
of B52 function does not significantly alter vGlut protein synthesis (Fig. 6C, middle). Although we detected no 
differences in ChAT protein levels our immunodetection in the CNS of 36 h old B52∆S2249 homozygous larvae and 
controls (elav-GAL4) reveals differences in ChAT localisation. In controls and mutants, ChAT accumulates along 
the longitudinal axon tracts. In controls, ChAT is present in bigger circular structures (arrow, Fig. 6D inset) and 
in smaller dots (arrowhead, Fig. 6D inset) but in mutants B52∆S2249 ChAT can mainly be detected in dots (Fig. 6D, 
Supplementary Fig. S3). We counted and measured the diameter of all ChAT positive vesicles in the 2nd and 3rd 
abdominal neuromeres (Fig. 6D). Compared to wild type (26.43 vesicles/segment; n = 18 segments), in B52∆S2249 
mutants the number of vesicles of above 1 μm diameter is significantly reduced (12.78 vesicles/segment; n = 14 
segments; p > 0.001). We detect no significant differences in the average diameter size between vesicles in wild 
type (2.05 μm) and B52∆S2249 (2.2 μm).
Together our data indicates that increased B52 levels affect splicing of ChAT in 2nd instar larvae. In contrast 
to embryos with functionally depleted B52, B52 loss or gain in 2nd instar larvae does not change ChAT protein 
expression or Acetylcholine levels.
Discussion
We tested if the analysis of the transcriptome of single neurons removed from the ventral nerve cord of living 
brains can be used to identify new molecules directing neuronal network formation. We harvested single MP2 
neurons at a time when axonal guidance draws to a close and the first evoked action potentials can be recorded26. 
We focused on MP2 neurons because of their common origin and their two very distinct fates, an anterior pro-
jecting cholinergic interneuron versus a posterior projecting interneuron destined for apoptosis. Our chosen time 
point of cell removal, stage 17, a time when neurons are nearly fully differentiated and when neuronal networks 
become functional, should increase the possibility of identifying transcripts involved in network function and 
to exclude transcripts controlling cell determination. Indeed, the transcripts we discovered are involved in cell 
contact, cellular maintenance and epigenetic control of chromatin states. Due to their different fates we expected 
a vast array of transcriptional differences between the two MP2 siblings, yet we only discovered 7 out of 2631 
transcripts, which are differentially expressed (threshold 1.4x). This number of differentially expressed transcripts 
is dependent on the high stringency filters we applied and will also vary in the course of development. Yet, the lin-
eage of MP2 neurons also sets them apart from all other interneurons in the lateral CNS because their precursor 
only divides once, generating neurons directly and not via a transient ganglion mother cell (gmc)5. Our prelimi-
nary results comparing the transcriptome of sibling interneurons from a neuroblast (Nb) following a conventional 
division pattern (Nb5-2) reveal a much higher diversity. In contrast to MP2, which divides only once, Nb5-2 can 
Homozygous B52ΔS2249 mutants show a slight but not significant decrease in short contractions and a significant 
decrease in long contractions (p = 0.022, t-test). Bars represent standard error. N = 5 for all genotypes. (B) 
Depletion of B52 function (UAS-BBS/+, elav-GAL4/+) interferes with splicing of ChAT pre-mRNA in late 
embryos. Top: Schematic drawing of the ChAT gene structure in the examined region. Red lines mark position 
of primers. Bottom: Compared to controls (elav-GAL4), B52 depletion reduces splicing efficiency of ChAT 
intron 2 and intron 4–7. kB, kilobases; s, spliced; u, unspliced. (C) Compared to elav-GAL4, ChAT protein 
is significantly reduced in UAS-BBS/+, elav-GAL4/+ (p = 0.0015) and slightly reduced in B52Δ2249 mutants 
(p = 0.047, t-test). Western blot of nerve cords removed from late stage 17 embryos. VGlut expression does not 
change in gain or loss of B52. Graphs indicate relative band intensity of Western blot. Actin was used as loading 
control. Band intensity was adjusted to loading controls and normalized to elav-GAL4 control. Images are 
cropped. For uncut blots see Supplementary Fig. S4. (D) Depletion of B52 function (UAS-BBS/+, elav-GAL4/+) 
reduces Acetylcholine production. Graph presents average Acetylcholine concentration per embryo in stage 17 
control (elav-GAL4) and B52 depleted embryos (UAS-BBS/+, elav-GAL4/+). Bars represent standard error  
(n = 2 experiments, 16 embryos/experiment, p < 0.001, t-test).
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Figure 6. Gain but not loss of B52 affects splicing of ChAT. Genotypes are indicated at the top or bottom of 
each panel: elav-GAL4 and B52ΔS2249/TM3, control; elav-GAL4/UAS-GFP-B52, gain of B52; UAS-BBS/+; elav-
GAL4/+, B52 depletion; B52ΔS2249, B52 homozygous mutant. (A) Top panel: In 36 h larvae, increased neuronal 
expression of B52 (elav-GAL4/UAS-GFP-B52) raises the amount of B52 RNA and loss of B52 in heterozygous 
(B52Δ2249/TM3) and homozygous larvae (B52Δ2249) reduces B52 mRNA. In homozygous mutants B52 mRNA is 
barely detectable. Bottom panel: Gain of B52 mRNA results in a reduced efficiency of splicing of Intron 4–7 of 
ChAT. Whereas loss of B52 shows the opposite effect and splicing of intron 4–7 in B52Δ2249 mutant larvae seems 
as efficient as in controls (elav-GAL4). Images are cropped. For uncut images see Supplementary Fig. S4.  
(B) Loss of B52 does not change Acetylcholine synthesis in larval brains. Average acetycholine level per larval 
brain is shown (n = 2 experiments, 10 larval brains/experiment, bars are standard error). (C) Neither gain nor 
loss of B52 changes levels of ChAT protein (top) or vGlut levels (middle). Tubulin was used a loading control 
(bottom). Band intensity was adjusted to loading controls and normalized to elav-GAL4 control. Graphs 
represent band intensity for ChAT and vGlut as indicated on top of each graph. Three independent lysates 
were prepared, separated by SDS gelectrophoresis and blotted. Error bars show standard error. Images of blots 
are cropped. For uncut images see Supplementary Fig. S4. (D) Loss of B52 does not cause ectopic or increased 
expression of ChAT. ChAT in control larval CNS (left) and B52 homozygous mutants (middle) can be mainly 
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undergo up to 20 divisions, generating 20 gmc’s and 40 neurons. During these divisions a cascade of tempo-
ral factors controls changes in neuronal identity43. Applying the same stringent criteria as in our MP2 analysis, 
two interneurons removed from the same Nb5-2 lineage differ in 569 transcripts out of 1226 (46,2%; Bossing, 
unpublished results). Comparing interneurons from different Nbs (Nb6-1 vs Nb7-1) increases molecular diversity 
even further, 633 out of 1232 transcripts are differentially expressed (51.4%, Bossing, unpublished results). These 
preliminary results are in line with previous publications reporting a high molecular diversity of interneurons44,45. 
The low number of differential expressed transcripts between MP2 neurons seems to be the exception.
The SRSF protein B52 regulates ChAT splicing. One transcript we found expressed higher in dMP2 
than vMP2 encodes the SRSF protein B52, which is the closest Drosophila orthologue to human SRSF6. SRSF 
proteins were first characterised as pre-mRNA alternative and constitutive splicing factors46. In addition to 
their role in splicing, several SRSF proteins have been shown to regulate transcription elongation, RNA export, 
decay, translation47, and for B52, transcriptional regulation48. Interestingly, SRSF4, one of the human orthologues 
of B52 expressed in the CNS, has been shown to be involved in alternative splicing of Tau and the origin of 
Frontotemporal Dementia31,49. We studied the function of B52 in neural development in Drosophila in more 
detail. B52 is maternally deposited and expressed throughout the CNS. Since we chose to analyse the transcrip-
tome of MP2 siblings at the end of embryogenesis, we would not expect B52 to be a crucial factor in cell fate 
determination. Indeed neural depletion of B52 function by pan-neural expression of a RNA aptamer or in subsets 
of neuroblasts and their progeny does not create gross morphological defects. Yet, we discovered that functional 
depletion of B52 affects axonal growth and the pre-mRNA splicing and biosynthesis of ChAT.
One of the B52 splicing targets identified by genomic systematic evolution of ligands by exponential enrich-
ment (SELEX)50 and co-immunoprecipitation51 is the BTB/POZ transcription factor longitudinal lacking, (lola), 
which controls axon extension via the transcription of spire, an actin nucleation protein52. We show that inter-
ference with B52 function in dMP2 increases axonal growth. Whereas increased expression of B52 does not alter 
axonal growth suggesting a saturation of the B52 target in the wild type condition. Thus we speculate that B52 
may control axonal growth via splicing of lola for which at least 25 different isoforms have been reported (www.
flybase.org).
In contrast to lola pre-mRNA, ChAT pre-mRNA has not yet been identified as a B52 splicing target. Therefore 
we cannot exclude that the observed splicing regulation of ChAT pre-mRNA is indirectly mediated via a yet 
unknown B52 target. In the embryo, depletion of B52 function by the expression of UAS-BBS results in accu-
mulation of unspliced ChAT pre-mRNA and consequently a reduction in ChAT protein synthesis and reduced 
acetylcholine synthesis. Cholinergic interneurons are the only excitatory input for embryonic motor neurons. 
During the transition from uncoordinated muscle twitches to coordinated peristaltic muscle contractions, the 
shape of motorneuronal dendrites is fine tuned by presynaptic contact as well as acetylcholine release. In ChAT 
mutants, larvae do not hatch and motorneuronal dendrites overgrow39. A reduction of ChAT synthesis and ace-
tylcholine synthesis as seen upon embryonic B52 functional depletion may therefore cause the observed increase 
in uncoordinated movements and the hatching delay.
At the end of their life B52 homozygous mutant larvae are smaller than their heterozygous siblings and appear 
paralysed. Both phenotypes might be explained by deficient Ecdysone signalling. A reduction in larval size is 
not unexpected because the Ecdysone receptor (EcR)50 and many ecdysone inducible transcripts51 have been 
identified as B52 splicing targets. Larvae without EcR function do not moult, remain small and gradually become 
immobile and insensitive to touch53.
Pre-mRNA splicing depends on the stoichiometry of snRNPs and splice factors. In addition, phosphorylation 
of SRSF proteins defines their binding specificity, function and localisation54,55. The accumulation of unspliced 
ChAT pre-mRNA caused by the depletion of B52 function in embryos and by targeted expression of B52 in 
2nd instar larvae, two opposing manipulations, support that stoichiometry plays an important role for efficient 
splicing. Yet, changes in stoichiometry appear insufficient to explain the efficient splicing of Cha introns 4–7 in 
B52∆S2249 mutant larvae, which show a severe reduction of B52 mRNA. The different splicing phenotypes between 
mutant and functionally depleted larvae may be due to partial redundancy between B52 and the second SRSF 
protein in Drosophila, Asf/SRSF2. Target specificity of B52 and Asf proteins shows some overlap51. Therefore the 
increase in artificial B52 binding sites with the expression of the BBS aptamer may not only titrate out B52 but also 
Asf leading to a functional depletion of both SRSF proteins. In contrast, in B52 homozygous mutants, the loss of 
B52 protein can still be compensated by the presence of Asf protein.
Our work shows that functional depletion of B52 reduces ChAT pre-mRNA splicing and ChAT protein syn-
thesis although the exact regulation of ChAT pre-mRNA by B52 awaits further investigation. The lower expres-
sion of B52 in the cholinergic vMP2 than in the non-cholinergic dMP2 may be a compromise allowing vMP2 to 
still splice ChAT pre-mRNA efficiently and continue axonal growth.
Bipolar disorder (BD) is a devastating mental disease, in which the patient fluctuates between depressive and 
maniac mood swings. Elevated acetylcholine levels are the trigger for the depressive phases56. A recent study tried 
to identify transcriptional changes in the dorsolateral prefrontal cortex in postmortem brains of patients who 
detected along the longitudinal axon tracts. Yet, in control embryos, ChAT is present in structures resembling 
neuronal cell bodies (arrow, inset) as well as in small vesicles (arrowhead). In mutants, ChAT is limited to 
vesicles. Insets are 1.6x magnifications of framed area. Graph (right) represents the number of ChAT positive 
vesicles/neuromere. Vesicles in 2nd and 3rd abdominal neuromere with a diameter above 1 μm were counted. 
Wild type: 26.43 vesicles per segment, n = 18; B52ΔS2249: 12.78 vesicles/neuromere, n = 14. p > 0.001; Bars 
represent standard error. Horizontal views, Anterior is up. Scale: 10 μm (16 μm in inset).
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suffered from bipolar disorder. Only five differentially expressed genes and 12 differentially expressed transcripts 
were discovered57. Interestingly, one of the transcripts encodes for the SRSF5 protein, an orthologue of B52, 
which was significantly downregulated in BD patients. We show that depletion of B52 function decreases ChAT 
protein, and subsequently acetylcholine levels. Therefore, not only are ChAT and SRSF proteins widely conserved 
throughout the animal kingdom but also the mechanism controlling splicing of ChAT pre-mRNA by SRSF pro-
teins might be conserved.
Materials and Methods
Acetylcholine Measurements. Measurements of Acetylcholine were performed using a commercially 
available kit (Abcam) and a slightly modified protocol. Of each genotype 16 embryos or 10 larval brains were 
transferred into 1.5 ml centrifuge tubes, spun at maximum speed in a table centrifuge at 4 oC, shock frozen in 
liquid nitrogen and ground up frozen in 40 ul assay buffer with a pestle attached to an electronic screwdriver at 
RT for 3 min. The sample was frozen again at −20 oC for 10 min. Frozen sample was ground again for 2 min until 
completely thawed. Finally, the sample was spun at maximum speed in a table centrifuge at 4 oC for 2 min. To 6 ul 
supernatant or calibration standard 2 ul Enzyme Mix and for two lysates an additional 2 μl Acetylcholinesterase 
was added. Samples were incubated for 30 min in the dark at RT. Adsorption of calibration standards and lysates 
were measured on a Nanodrop at 570 nm and 600 nm.
Fly stocks. We used the following fly stocks: eag-GAL458, elav-GAL459, GAL4CY27 60, P{lacW} B52(s2249P}/TM3 
(Bloomington 10265), UAS-BBS34; UAS-GFP-B5251; UAS-mCD8-GFP61; UAS-myr-GFP62, UAS-B52RNAi (TRiP.
HMS01661, Bloomington 111038), UAS-B52RNAi (KK108253, VDRC v101740).
Generation of B52 mutants. We generated the B52 mutant, B52Δs2249, by crossing a stable source of trans-
posase (Δ2-3sb/TM6b) with the hypomorphic B52 allele, P{lacW} B52(s2249P}/TM3. F2 progeny were selected 
for white eyes and crossed to each other to test for lethality. The genomic DNA of lethal strains was tested for 
deletions by PCR using primers located at −967 Bp, 3’UTR of Hrb87f, and at +1728 Bp. Sequencing identified a 
deletion starting at −456 Bp and extending to +165 Bp, eliminating the transcriptional start and the first 55aa of 
the ORF. B52Δs2249 fails to complement P{lacW} B52(s2249P} and PCR analysis of larval cDNA confirms that the 
deletion does not affect the expression of the Hrb87f gene immediately upstream of B52. B52Δs2249 homozygous 
mutants die as 2nd instar larvae around 40 h after larval hatching.
Immunohistochemistry, Western Blots and generation of mosaic expression. The following anti-
bodies were used: BP102 (mouse, 1:1000; kind gift from N. Patel), anti-ChAT (mouse, 1:50 for immuno, 1:500 
for Western Blots; DSHB), anti-FasII (mouse, 1:20; DSHB), anti-Futsch (mouse, 1:20; DSHB), anti-GFP (rabbit, 
1:1000; kind gift from U. Mayor), anti-GFP (mouse, 3E10, 1:50; Life Technologies), anti-Odd (rabbit, 1:1000; 
kind gift from Jim Skeath), anti-vGlut (rabbit, 1:1000 in Immuno and 1:10,000 in Western Blots; kind gift from 
H. Aberle). Secondary antibodies were coupled to Alexa 488, 568 (Life Technologies). Immunohistochemistry 
was performed as described in63. Embryos were embedded in 70% Glycerol/Vectashield (3/1).
Due to increased background using whole embryo lysates, we blotted only lysates of dissected late embryonic 
brains (stage 17). 8 embryonic or 5 larval brains were transferred into 1.5 ml centrifuge tubes and lysed for 2 min 
with a plastic pestle attached to an electronic screwdriver in a 200 ul mixture of HEPES buffer (0.32 M sucrose, 
4 mM HEPES, 0.5% Complete Protease Inhibitor [Roche Applied], pH = 7.4) and Laemmli loading buffer. After 
lysis, samples were boiled for 5 min and stored at −20 oC. Gel separation at 120 V, wet transfer at 30 mA overnight 
at 4 oC, antibody incubation and luminescence detection (Super Signal West pico; Pierce) followed standard pro-
cedures. Band intensity was analysed using the Gel Analysis module in Image J.
Mosaic expression of myr-GFP was generated as described previously36. To reduce the frequency of cells 
expressing GFP we injected UAS-myr-GFP plasmids at a concentration of 200 ng/ul into CY27GAL4 embryos at 
2.5 hours after egg lay (late syncytial blastoderm). Embryos were inspected under epifluorescence at stage 17 and 
subjected to immunohistochemistry36.
In situ hybridisation. In situ hybridisation with in vitro transcribed B52 Digoxigenin labelled RNA has been 
described previously60. Immunohistochemistry was performed after completion of the hybridisation protocol. 
For signal amplification we used secondary antibodies coupled to alkaline phosphatase together with Fast Red 
(Sigma). To quantify RNA expression we collected and merged four Z sections (0.35 μm intervals) around the 
biggest diameter of each neuron. We used Photoshop CS6 to select the outline of each neuron and measure the 
area and integrated density (sum of all intensities). To adjust for different cell sizes we divided the integrated 
density/area. In total, we measured selected ten neurons of each type from thoracic and abdominal segments of 
three embryos.
Single cell transcriptome and RT-PCR. The protocols for the generation of cDNA from single cells, 
microarray hybridisation and the statistical analysis of array results have been published in detail previously25.
To generate 1st strand templates for the testing of splice forms, we dissected 10 embryonic and 5 larval CNSs 
from each genotype and harvested the RNA using the GenElute Mammalian Total RNA Kit (Sigma). Samples 
were analysed by reverse transcribing total RNA from larval CNSs using Superscript II (Clontech) and primers 
from the Smarter PCR cDNA synthesis kit (Clontech). We tested for the presence or absence of the splice product 
by amplification through 35 PCR cycles. For every PCR we used 100 ng of 1st strand cDNA as templates. All RT 
PCRs were repeated twice using freshly dissected CNSs as RNA source. The primers used are: Cha Intron 2 for-
ward CCAAAGAAATGGCTCTCAACG, Cha Intron 2 reverse CAGCAGATACTGATGCAGCCG, Cha Intron 
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4–7 forward GCAGGACTCGCAGTTCCTGCC, Cha Intron 4–7 reverse CGGATGCGGATTGTAGGAGCA, 
vAChT forward GGATGTCGTGCAAGTTGAGTGG, VAChT reverse GGAAATTGCTTAGCTCTCGC.
Time lapse movies. 2 h old embryos were bleached, aligned on agar slices, and transferred onto glue coated 
coverslips. Embryos were covered with 10 s Voltalef Oil and allowed to develop another 16 h at 25 oC. 18 h old 
embryos were inspected under a dissecting microscope every 30 min for tracheal filling. After tracheal tubes were 
filled with air we started the recording. Embryos were recorded on an inverted Nikon Eclipse TE300 with 100x 
magnification using a Hamamatsu Orca 100 camera and HCImage as image capture software. During recording, 
embryos were kept in a dark room with the temperature set at 20 °C. The intensity of transmitted light projected 
onto the embryos was set at minimum level. Time interval between each capture was set at 5 second for a record-
ing period of 2 hours or more.
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